These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19740396)

  • 1. Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive.
    Braun M; Elshoff JP; Andreas JO; Müller LI; Horstmann R
    Br J Clin Pharmacol; 2009 Sep; 68(3):386-94. PubMed ID: 19740396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine.
    Braun M; Cawello W; Boekens H; Horstmann R
    Br J Clin Pharmacol; 2009 Feb; 67(2):209-15. PubMed ID: 19094160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects.
    Sidhu J; Job S; Singh S; Philipson R
    Br J Clin Pharmacol; 2006 Feb; 61(2):191-9. PubMed ID: 16433873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No clinically relevant drug-drug interactions when dalcetrapib is co-administered with a monophasic oral contraceptive (Microgynon® 30).
    Young A; Anzures-Cabrera J; Derks M
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):248-56. PubMed ID: 22456295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE; Mesure R
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects.
    Liu Y; Tomlinson B; Guo J; Asgharnejad M; Bauer L; Surmann E; Guo X; Elshoff JP
    Clin Ther; 2018 Jul; 40(7):1108-1121.e8. PubMed ID: 30098648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotine.
    Cawello W; Fichtner A; Boekens H; Braun M
    Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):155-63. PubMed ID: 24052490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Staks T; Jütting G
    Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine.
    Elshoff JP; Cawello W; Andreas JO; Braun M
    Clin Pharmacol Drug Dev; 2014 May; 3(3):187-93. PubMed ID: 27128608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopa.
    Braun M; Cawello W; Andreas JO; Boekens H; Horstmann R
    J Clin Pharmacol; 2009 Sep; 49(9):1047-55. PubMed ID: 19628729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel.
    Olsson B; Landgren BM
    Clin Ther; 2001 Nov; 23(11):1876-88. PubMed ID: 11768839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziprasidone and the pharmacokinetics of a combined oral contraceptive.
    Muirhead GJ; Harness J; Holt PR; Oliver S; Anziano RJ
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):49S-56S. PubMed ID: 10771454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of avosentan (SPP3OI) on the pharmacokinetics of a second generation oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers.
    Dieterle W; Mann J
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):668-74. PubMed ID: 17190377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.
    Heger-Mahn D; Pabst G; Dienel A; Schläfke S; Klipping C
    Drugs R D; 2014 Dec; 14(4):265-72. PubMed ID: 25319228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, safety, and tolerability of rotigotine transdermal system in healthy Japanese and Caucasian subjects following multiple-dose administration.
    Cawello W; Kim SR; Braun M; Elshoff JP; Masahiro T; Ikeda J; Funaki T
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):353-62. PubMed ID: 25773763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
    Cawello W; Rosenkranz B; Schmid B; Wierich W
    Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone.
    Lin WH; Feng HP; Shadle CR; O'Reilly T; Wagner JA; Butterton JR
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1107-13. PubMed ID: 24992979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome.
    Elshoff JP; Cawello W; Andreas JO; Mathy FX; Braun M
    Drugs; 2015 Apr; 75(5):487-501. PubMed ID: 25795100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, safety and tolerability of rotigotine transdermal patch in healthy Japanese and Caucasian subjects.
    Cawello W; Kim SR; Braun M; Elshoff JP; Ikeda J; Funaki T
    Clin Drug Investig; 2014 Feb; 34(2):95-105. PubMed ID: 24178238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic properties and tolerability of rotigotine transdermal patch after repeated-dose application in healthy korean volunteers.
    Kim BH; Yu KS; Jang IJ; Soo Lim K; Kim JR; Elshoff JP; Andreas JO; Braun M; Cawello W
    Clin Ther; 2015 Apr; 37(4):902-12. PubMed ID: 25791613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.